Quotient Sciences Announces Significant Growth in Workforce at Alnwick, UK, Facility
Quotient Sciences has grown the workforce at its Alnwick, UK, facility by 20% over the past 2 years.
Quotient Sciences Completes Major Expansion of Drug Substance Manufacturing Facility
A £6 million project expands Quotient Sciences' Alnwick, UK into a state-of-the-art drug substance manufacturing facility that can deliver integrated support for customers from candidate selection through to early clinical development and beyond.
Quotient Sciences Completes Qualification of GastroPlus® PBPK Modeling Software
Quotient Sciences’ Modeling and Simulation (M&S) team has recently completed qualification of GastroPlus software for physiologically based pharmacokinetic (PBPK) modeling.
Quotient Sciences Expands UK Facilities to Support the Delivery of Translational Pharmaceutics® Programs
Quotient Sciences has completed major investments and expansions at its Nottingham, UK and Reading, UK, facilities to support the delivery of fully integrated drug development programs.
Quotient Sciences Completes Million Dollar Pharmacy Expansion at Miami Clinic
State-of-the-Art Compounding Pharmacy Will Accelerate Early Development Programs
Quotient Sciences Constructs State-of-the-Art Early-Phase Formulation and Manufacturing Facility in U.S.
Quotient Sciences announces a significant expansion to its operations in the U.S. with the opening of a state-of-the-art, 45,000-square-foot facility located near Philadelphia, in Garnet Valley, PA. The $15 million investment will create a center of excellence for early-phase formulation development and clinical trial manufacturing.